相关实验视频
Updated: Jan 15, 2026

10:42
Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
17.8K
口腔中的微生物失生症决定了青少年的肥胖状况
Md Zubbair Malik1, Rasheeba Nizam1, Sindhu Jacob1
1Department of Translational Research, Dasman Diabetes Institute, Dasman, Kuwait City, Kuwait.
Cellular and molecular life sciences : CMLS
|October 11, 2025
概括
科威特青少年的肥胖与较低的口腔细菌多样性有关. 像Prevotella melaninogenica和Veillonella物种这样的特定细菌与更高的体重指数 (BMI) 有关,这表明微生物组可能是体重管理的潜在目标.
科学领域:
- 微生物学 微生物学
- 人类健康 人类健康 人类健康
- 青少年健康 青少年健康
背景情况:
- 科威特青少年肥胖率上升是一个公共卫生问题.
- 口腔微生物组在青少年肥胖中的作用尚不清楚.
- 了解这些变化对于制定有针对性的干预措施至关重要.
研究的目的:
- 研究身体质量指数 (BMI) 对科威特青少年唾液微生物群多样性和组成的影响.
- 确定与肥胖和超重状态相关的特定口腔微生物生物标志物.
- 分析与不同BMI类别相关的口腔微生物群中的功能转变.
主要方法:
- 来自62名科威特青少年的唾液DNA提取,分别按BMI类别 (体重不足,正常,超重,肥胖).
- 16S对口腔微生物组进行分类学和功能分析的元基因组分析.
- 同时发生的网络分析和in-silico代谢概况.
主要成果:
- 在口腔细菌多样性和肥胖之间观察到显著的反向关系.
- 与体重正常的同龄人相比,肥胖和超重的青少年表现出较低的微生物多样性.
- 发现了Prevotella melaninogenica,Veillonella dispar和Veillonella parvula作为肥胖和超重的潜在生物标志物.
结论:
- 口腔微生物群的分类学和功能性改变与科威特青少年的不同BMI类别有关.
- 特定的微生物种群和代谢途径与体重状况有关.
- 研究结果表明,口腔微生物组是未来肥胖管理策略的潜在目标.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Assessment of the Mouth
1.1K
A thorough mouth assessment, including inspection and palpation of the lips, gums, tongue, tonsils, uvula, and pharynx, is crucial in detecting potential health issues. Diseases ranging from oral cancer to systemic conditions like diabetes could be identified early through careful oral examination. This article provides a detailed guide on conducting a comprehensive mouth assessment.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
1.1K
Bulimia Nervosa
679
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
679
Factors Influencing Microbial Growth: Osmolarity
736
Osmolarity is the measure of solute concentration in a solution. It plays a critical role in determining water availability for organisms. Water moves across semipermeable membranes through osmosis, flowing from regions of lower solute concentration (more dilute) to regions of higher solute concentration (more concentrated).In high-solute environments, microbial cells lose water, leading to dehydration and inhibited growth. The extent to which water is available to microbes in such environments...
736
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
246
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
246
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
166
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
166

